Tuesday, November 24, 2009, 2:36pm EST - Canadian Markets close in 1 hour and 24 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

DepoMed Inc. (DEPO)

 At 14:21 EST: 3.26 USD  Down 0.03 (0.91%)  
MORE ON DEPO
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Depomed, Inc. (NGM:DEPO) Delayed quote dataEdit
Last Trade: 3.26 USD
Trade Time: 2:21PM EST
Change: Down 0.03 (0.91%)
Prev Close: 3.29
Open: 3.29
Bid: 3.25 x 3200
Ask: 3.26 x 100
1y Target Est: 7.83
Day's Range: 3.23 - 3.29
52wk Range: 1.37 - 6.40
Volume: 131,074
Avg Vol (3m): 849,157
Market Cap: 169.56M
P/E (ttm): N/A
EPS (ttm): -0.58
Div & Yield: N/A (N/A%)
DepoMed Inc. (DEPO)
1d  5d  3m  6m  1y  2y  5y  max 
 Add DEPO to Portfolio   Download Data

HEADLINES
• Depomed to Present at Piper Jaffrays 21st Annual Health Care Conference
Business Wire (Tue 9:02am)
• Depomed Promotes William Callahan to Vice President of Operations
Business Wire (Wed, Nov 18)
• Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza
at Seeking Alpha (Mon, Nov 16)
• Depomed Ranked #13 on Deloittes Technology Fast 500TM
Business Wire (Mon, Nov 16)
• DEPOMED INC Financials
EDGAR Online Financials (Fri, Nov 13)
• Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA®
Business Wire (Tue, Nov 10)
• DEPOMED INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 10)
• Serada Half Price Sale: DepoMed's Stock Price Poised to Climb
at Seeking Alpha (Sun, Nov 8)
• DEPOMED INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
• Depomed to Present at Merriman Curhan Fords Investor Summit 2009
Business Wire (Tue, Nov 3)
• Depomed swings to $1.4M Q3 profit
at bizjournals.com (Thu, Oct 29)
• Depomed Earnings Call scheduled for 5:00 pm ET today
CCBN (Thu, Oct 29)
More Headlines for DEPO...
ANALYST
EPS Est (next year) (Dec-09) : -0.50
EPS Est (in 2 years) (Dec-10) : -0.56
Avg Rec (current)*: 1.8
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Depomed, Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary oral drug delivery technologies in the United States.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices